ROYAL BANK OF CANADA - MERIDIAN BIOSCIENCE INC ownership

MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 181 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of MERIDIAN BIOSCIENCE INC
ValueSharesWeighting
Q4 2022$562,000
+12.6%
16,910
+6.9%
0.00%
Q3 2022$499,000
-61.5%
15,825
-62.8%
0.00%
Q2 2022$1,295,000
+168.7%
42,576
+129.0%
0.00%
Q1 2022$482,000
+6.9%
18,596
-15.8%
0.00%
Q4 2021$451,000
+37.9%
22,078
+29.8%
0.00%
Q3 2021$327,000
-8.7%
17,013
+5.5%
0.00%
Q2 2021$358,000
-13.7%
16,124
+2.0%
0.00%
Q1 2021$415,000
-34.4%
15,804
-53.3%
0.00%
Q4 2020$633,000
-59.2%
33,826
-63.0%
0.00%
-100.0%
Q3 2020$1,552,000
+88.6%
91,389
+158.8%
0.00%
Q2 2020$823,000
+207.1%
35,307
+11.1%
0.00%
Q1 2020$268,000
-61.9%
31,786
-55.8%
0.00%
Q4 2019$703,000
+1.4%
71,974
-1.5%
0.00%
Q3 2019$693,000
-23.0%
73,074
-3.6%
0.00%
Q2 2019$900,000
-3.3%
75,771
+43.3%
0.00%
Q1 2019$931,000
+10.6%
52,861
+9.0%
0.00%
Q4 2018$842,000
+7.4%
48,495
-8.6%
0.00%
Q3 2018$784,000
-3.6%
53,060
+3.7%
0.00%
Q2 2018$813,000
+16.1%
51,175
+3.9%
0.00%
Q1 2018$700,000
+5.4%
49,277
+3.9%
0.00%
Q4 2017$664,000
-9.9%
47,417
-8.1%
0.00%
Q3 2017$737,000
-4.3%
51,572
+5.4%
0.00%
Q2 2017$770,000
+4.2%
48,916
-8.7%
0.00%
Q1 2017$739,000
+6.9%
53,573
+37.1%
0.00%
Q4 2016$691,000
+7.1%
39,075
+16.7%
0.00%
Q3 2016$645,000
-25.6%
33,494
-24.7%
0.00%
-100.0%
Q2 2016$867,000
+12.3%
44,499
+18.7%
0.00%
Q1 2016$772,000
-4.0%
37,504
-4.2%
0.00%
-100.0%
Q4 2015$804,000
+12.1%
39,131
-6.7%
0.00%0.0%
Q3 2015$717,000
-21.7%
41,922
-14.7%
0.00%0.0%
Q2 2015$916,000
+7.5%
49,131
+10.0%
0.00%0.0%
Q1 2015$852,000
-54.6%
44,653
-60.8%
0.00%0.0%
Q4 2014$1,876,000
-82.1%
114,036
-80.8%
0.00%
-85.7%
Q3 2014$10,484,000
-15.3%
592,620
-1.2%
0.01%
-12.5%
Q2 2014$12,375,000
-6.8%
599,578
-1.6%
0.01%
-20.0%
Q1 2014$13,273,000
-28.2%
609,094
-12.6%
0.01%
-23.1%
Q4 2013$18,483,000
+12.3%
696,713
+0.0%
0.01%0.0%
Q3 2013$16,461,000
+24.9%
696,621
+13.6%
0.01%
+18.2%
Q2 2013$13,182,000613,0970.01%
Other shareholders
MERIDIAN BIOSCIENCE INC shareholders Q4 2021
NameSharesValueWeighting ↓
SYQUANT CAPITAL SAS 134,804$4,47711.01%
Vazirani Asset Management LLC 115,774$3,8456.51%
FIFTH LANE CAPITAL, LP 185,914$6,174,2045.56%
NEXPOINT ASSET MANAGEMENT, L.P. 1,939,075$64,396,6815.01%
Crystalline Management Inc. 244,453$8,118,2844.08%
FNY Investment Advisers, LLC 51,000$1,6932.36%
HAVENS ADVISORS LLC 26,800$890,0282.26%
Euclidean Technologies Management, LLC 62,995$2,092,0641.99%
Sand Grove Capital Management LLP 537,060$17,8361.70%
Crabel Capital Management, LLC 120,337$3,9961.45%
View complete list of MERIDIAN BIOSCIENCE INC shareholders